dc.contributor
Institut Català de la Salut
dc.contributor
[Vargas-Accarino E, Feliu-Prius A, Barreira A, Ruiz-Cobo JC] Department of Medicine, Universitat Autònoma de Barcelona, Bellaterra, Spain. Grup de Recerca de les Malalties Hepàtiques, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. [Rando-Segura A] Servei de Microbiologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Palom A] Grup de Recerca de les Malalties Hepàtiques, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. CIBERehd, enfermedades hepáticas y digestivas, Madrid, Spain. [Martínez-Campreciós J, Romero-Vico J, Llaneras J] Grup de Recerca de les Malalties Hepàtiques, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. [Riveiro-Barciela M, Esteban R, Buti M] Department of Medicine, Universitat Autònoma de Barcelona, Bellaterra, Spain. Grup de Recerca de les Malalties Hepàtiques, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. CIBERehd, enfermedades hepáticas y digestivas, Madrid, Spain. Servei d’Hepatologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Rodríguez-Frías F] Grup de Recerca de les Malalties Hepàtiques, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Servei de Microbiologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain
dc.contributor
Vall d'Hebron Barcelona Hospital Campus
dc.contributor.author
Barreira Diaz, Ana
dc.contributor.author
Romero-Vico, Judit
dc.contributor.author
Llaneras Artigues, Jordi
dc.contributor.author
esteban, rafael
dc.contributor.author
Vargas-Accarino, Elena
dc.contributor.author
Rando Segura, Ariadna
dc.contributor.author
Palom, Adriana
dc.contributor.author
Feliu-Prius, Anna
dc.contributor.author
Martínez-Campreciós, Joan
dc.contributor.author
Ruiz Cobo, Juan Carlos
dc.contributor.author
Riveiro-Barciela, Mar
dc.contributor.author
RODRIGUEZ-FRIAS, FRANCISCO
dc.contributor.author
Buti Ferret, Maria
dc.date.accessioned
2025-02-22T17:42:49Z
dc.date.available
2025-02-22T17:42:49Z
dc.date.issued
2025-02-18T13:40:17Z
dc.date.issued
2025-02-18T13:40:17Z
dc.identifier
Vargas-Accarino E, Rando-Segura A, Palom A, Feliu-Prius A, Martínez-Campreciós J, Barreira A, et al. Enhancing linkage to care for hepatitis B, D, and C patients: A retrospective-prospective study. Aliment Pharmacol Ther. 2024 Nov;60(10):1308–14.
dc.identifier
https://hdl.handle.net/11351/12624
dc.identifier
10.1111/apt.18227
dc.identifier
001299658700001
dc.identifier.uri
http://hdl.handle.net/11351/12624
dc.description.abstract
Patient care; Hepatitis B; Hepatitis D
dc.description.abstract
Atención a los pacientes; Hepatitis B; Hepatitis D
dc.description.abstract
Atenció als pacients; Hepatitis B; Hepatitis D
dc.description.abstract
Background
The WHO has set a goal to decrease viral hepatitis-related fatalities by 65% by 2030.
Aims
To locate and retrieve to care all individuals diagnosed with hepatitis B, D or C, and investigate why they were not linked to appropriate medical management.
Methods
We conducted a retrospective-prospective search for patients with hepatitis B, D or C virus (HBV, HDV and HCV) infection in the central laboratory database of the Barcelona northern health area (catchment population, 450,000). We reviewed records and contacted candidates for retrieval who were offered a specialist medical visit.
Results
We reviewed records of 3731 patients with viral hepatitis (January 2019–December 2022): 1763 HBsAg+, 69 anti-HDV+ and 1899 HCV-RNA+. Among these, 644 (37%) HBV, 20 (29%) HDV and 1116 (56%) HCV patients were not currently linked to care. The proportion of patients receiving appropriate care was higher in HBV and HDV (p < 0.0001), and a higher percentage of unlinked hepatitis C patients had low life expectancy/comorbidities (39%; p < 0.0001). After implementing the linkage strategy, 254 HBV, 16 HDV and 54 HCV patients were successfully reintegrated into care. Among 1780 patients requiring linkage, 638 (35.8%) had moved to another health area or were missing essential contact data.
Conclusions
Among patients with viral hepatitis who required appropriate specialist care and were eligible for contact, 64% with HBV, 100% with HDV and 27% with HCV were successfully reintegrated into care. Overall, 324 (47.2%) eligible patients were linked to care, indicating the success of this strategy.
dc.description.abstract
This work was supported by an unrestricted grant from Gilead Sciences and by Instituto de Salud Carlos III (ISCIII) (PI23/01065).
dc.format
application/pdf
dc.relation
Alimentary Pharmacology & Therapeutics;60(10)
dc.relation
https://doi.org/10.1111/apt.18227
dc.relation
info:eu-repo/grantAgreement/ES/PEICTI2021-2023/PI23%2F01065
dc.rights
Attribution-NonCommercial-NoDerivatives 4.0 International
dc.rights
http://creativecommons.org/licenses/by-nc-nd/4.0/
dc.rights
info:eu-repo/semantics/openAccess
dc.subject
Assistència sanitària
dc.subject
DISEASES::Digestive System Diseases::Liver Diseases::Hepatitis::Hepatitis, Viral, Human::Hepatitis B
dc.subject
DISEASES::Digestive System Diseases::Liver Diseases::Hepatitis::Hepatitis, Viral, Human::Hepatitis C
dc.subject
DISEASES::Digestive System Diseases::Liver Diseases::Hepatitis::Hepatitis, Viral, Human::Hepatitis D
dc.subject
HEALTH CARE::Health Services Administration::Patient Care Management
dc.subject
ENFERMEDADES::enfermedades del sistema digestivo::enfermedades hepáticas::hepatitis::hepatitis viral humana::hepatitis B
dc.subject
ENFERMEDADES::enfermedades del sistema digestivo::enfermedades hepáticas::hepatitis::hepatitis viral humana::hepatitis C
dc.subject
ENFERMEDADES::enfermedades del sistema digestivo::enfermedades hepáticas::hepatitis::hepatitis viral humana::hepatitis D
dc.subject
ATENCIÓN DE SALUD::administración de los servicios de salud::gestión de la atención al paciente
dc.title
Enhancing linkage to care for hepatitis B, D, and C patients: A retrospective-prospective study
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/publishedVersion
